awmsg logo

Medicines management resources awaiting your views

Medicines management resources aim to make medicines safer and more effective for patients. When we produce these resources, it is important that people who might be affected by them have a chance to give us their opinion. We also want to hear from the people who know most about the condition/treatment in question. This means that we ask doctors, nurses, pharmacists, pharmaceutical (drug) companies, patients, carers and patient representatives to read the papers and send us their feedback.

 

We need your help

Your input as a patient (or carer or patient representative) is vital, as the resources are meant to improve the care and treatment that you get. To produce the best possible guidance we need to hear first-hand the way these conditions and treatments affect patients.

You do not need to give a view on the whole paper; it may be that only one part is relevant to you.

Please note: Comments received during consultation are compiled in a report and considered by the development group. Each comment will be addressed and any changes to the document that are made as a result will be noted. The summary report including any comments submitted will be available upon request.

AWTTC reserves the right to summarise comments, where it is deemed appropriate, and to not publish comments if we consider their publication to be unlawful or otherwise inappropriate.

By submitting your comments, you are agreeing to them being used in line with the above.

To request a consultation comment summary, please contact: awttc@wales.nhs.uk. Please allow three weeks from the close of the consultation period for the summary to be available.

 

Documents awaiting your views:


Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile

The Adverse Drug Reaction (ADRe) Profile for mental health medicines, developed by Swansea University with input from other institutions, is an innovative, comprehensive approach to unifying the input of all healthcare professionals with the service user’s experiences. It aims to ensure that problems arising from service users’ mental health medicines are recognised and addressed, admissions are prevented, doses of antipsychotics and sedatives are reduced, service users’ well-being is improved, and all professionals and service users input into prescribing decisions, particularly repeat prescribing.

Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile - Consultation draft
Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile - Consultation pro-forma

Consultation closes: 23 November 2018



National Prescribing Indicators 2019-2020

Prescribing indicators are used to highlight therapeutic priorities for NHS Wales and compare the ways in which different prescribers and organisations use particular medicines or groups of medicines. Each of the NPIs for 2019–2020 has a focus on safety, stewardship or efficiency.

National Prescribing Indicators 2019-2020 - Consultation document
National Prescribing Indicators 2019-2020 - Consultation pro-forma

Consultation closes: 23 November 2018